Multitargets drug for Sepsis: Mechanistic studies of drug action through mitigating infection and inflammatory responses associated with sepsis. Oct 1, 2023 - Sep 30, 2025
Sepsis is a life-threatening clinical condition caused by an overreacting immune system fighting an infection. It is often treated with broad-spectrum antibiotics together with anti-inflammatory drugs. However, due to the heterogeneous nature of the...
Read More about Multitargets drug for Sepsis: Mechanistic studies of drug action through mitigating infection and inflammatory responses associated with sepsis..
All Projects (305)
Anchor partnership with Seaflo Asset Digital Twin Laboratory Sep 18, 2023 - Sep 17, 2026
This Asset Digital Twin Laboratory will bring together subsea asset engineers and research computer scientists to research, develop and deploy digital twins to help anticipate maintenance requirements to ensure the longevity of subsea structures, equ...
Read More about Anchor partnership with Seaflo Asset Digital Twin Laboratory.
Unlocking the biotechnological potential of Desertfilium tharense Aug 1, 2023 - Jul 31, 2024
Cyanobacteria, often known as blue-green algae, are an essential component of global ecosystems using light and carbon dioxide to produce organic carbon and oxygen. Consequently, they are found in diverse habitats including terrestrial and aquatic ha...
Read More about Unlocking the biotechnological potential of Desertfilium tharense.
Health Inequalities in the Food System Jul 1, 2023 - Sep 30, 2024
This builds on the existing Fio Food funded project. The focus of the research is on infant and maternal food insecurity.
One Health Prescribing – New Analytical Methods to Inform Formulary Changes to Chiral Pharmaceuticals for Environmentally Friendlier Medicines Oct 1, 2023 - Sep 30, 2027
There is a need to reduce pollutants at source instead of relying on water treatment for their removal. The One Health Breakthrough Partnership is working to reduce pharmaceutical pollution entering the environment. This includes prescribing medicine...
Read More about One Health Prescribing – New Analytical Methods to Inform Formulary Changes to Chiral Pharmaceuticals for Environmentally Friendlier Medicines.
Synthesis of substituted triazines and their investigation as corrosion inhibitors on mild steel and aluminium in corrosive environments Aug 1, 2023 - Dec 1, 2023
The serious consequences of the corrosion process have become a problem of worldwide significance - corrosion is the destructive attack of a material by reacting to its environment. Corrosion causes plant shutdowns, wastes valuable resources, causes...
Read More about Synthesis of substituted triazines and their investigation as corrosion inhibitors on mild steel and aluminium in corrosive environments.
Building Standards Apps - May 20, 2023 - Dec 14, 2023
Creation of a minimum viable design/product and a specification for an information repository and an inspection app for building standards in Scotland.
AI-Powered Inspection: Transforming Oil and Gas Asset Management Mar 5, 2024 - Mar 4, 2026
To develop an intelligent and data-driven framework to automate inspection tasks for offshore assets, to provide companies with intelligent monitoring and management of their structures and allow lifespan prediction. This will be achieved by utilisin...
Read More about AI-Powered Inspection: Transforming Oil and Gas Asset Management.
Exploring the anti-atherogenic properties of a compound derived from Amaryllidaceae (Daffodil) Sep 1, 2023 - Apr 30, 2024
Agroceutical Products Ltd (APL) produces sustainable quantities of the naturally derived alkaloid galanthamine from daffodils, which is a key active pharmaceutical used for the treatment of Alzheimer’s disease. Daffodils contain an abundance of other...
Read More about Exploring the anti-atherogenic properties of a compound derived from Amaryllidaceae (Daffodil).
Bioactivity of a compound derived from Amaryllidaceae (Daffodil) in a C.elegans model of obesity Sep 1, 2023 - Apr 30, 2024
A previous proof-of-concept study demonstrated that an alkaloid extracted from daffodil bulbs by Agroceutical Products Ltd (APL), alongside sustainable galanthamine production (alkaloid used for Alzheimer’s disease management), selectively reduced re...
Read More about Bioactivity of a compound derived from Amaryllidaceae (Daffodil) in a C.elegans model of obesity.
AI Powered Automated Vulnerability Anti-patterns System - Datalab Jun 21, 2023 - Dec 20, 2023
CyberShell Solutions and Robert Gordon University have teamed up to develop a Software-as-a-Service (SaaS) platform for Cyber Threat Intelligence. This platform provides support on software security vulnerabilities for DevOps teams by scanning code i...
Read More about AI Powered Automated Vulnerability Anti-patterns System - Datalab.
Yes/No shellfish toxin test Sep 1, 2023 - Mar 31, 2024
The UK shellfish industry uses qualitative tests for management of range of toxins in shellfish products. The only supplier of these tests, Neogen will discontinue these tests by the end of 2023. CyanSol group and partners are dedicated to developin...
Read More about Yes/No shellfish toxin test.
Silver Saplings: An initial review and evaluation of intended positive intervention change and wellbeing effects Sep 1, 2023 - Feb 29, 2024
Diverse wellbeing interventions and initiatives can have manifold positive impacts on individuals perceptions of wellbeing, however structured evaluations are required in order to capture and assess meaningful change. This initial project phase plans...
Read More about Silver Saplings: An initial review and evaluation of intended positive intervention change and wellbeing effects.
Design and manufacturing of large-scale portable hydrogen composite tanks for compressed gas storage Apr 1, 2024 - Oct 31, 2026
To develop a lightweight, low-cost high-pressure hydrogen storage vessel of hybrid metal and composite construction. Once developed, the new vessel will be optimised to achieve manufacturing scalability and ensure its design can be easily adapted to...
Read More about Design and manufacturing of large-scale portable hydrogen composite tanks for compressed gas storage.
One Health Medicine – developing a predictive tool for pharmaceuticals in wastewater Oct 30, 2023 - Nov 1, 2024
Medicines are used everyday by humans. However, they can be detrimental to aquatic life. Pharmaceuticals enter the environment following human excretion and transport through wastewater systems. The danger pharmaceuticals pose is location specific de...
Read More about One Health Medicine – developing a predictive tool for pharmaceuticals in wastewater.
WiKatoni : Empowering Workforce Efficiency via a CloodCBR-Enabled Data Hub and LLM-Driven Workflows for Sustainable Knowledge Management Feb 19, 2024 - Feb 18, 2026
To develop WiKatoni, an AI-powered platform, for engineering knowledge management using Large Language Models and a user interface to enhance knowledge retention, sharing, and utilisation. By employing Case-Based Reasoning, the project enables conti...
Read More about WiKatoni : Empowering Workforce Efficiency via a CloodCBR-Enabled Data Hub and LLM-Driven Workflows for Sustainable Knowledge Management.
AI-Driven Framework for Remote Inspection Apr 1, 2024 - Mar 31, 2026
To develop an Al-driven lmmersive Inspection Platform for energy sector asset inspections, leveraging multi-modal data, artificial intelligence, and immersive augmented/virtual reality technologies, aimed at enhancing efficiency, accuracy, and predic...
Read More about AI-Driven Framework for Remote Inspection.
How do fresh whole blood and blood component therapies containing additive solutions alter the structure and stability of a blood clot during traumatic bleeding? Dec 1, 2023 - Nov 30, 2024
In a military setting, bleeding is the primary cause of preventable death in patients suffering from polytrauma and massive haemorrhage. Access to hospital care and blood products is limited by location, logistics and personnel. Pre-hospital blood in...
Read More about How do fresh whole blood and blood component therapies containing additive solutions alter the structure and stability of a blood clot during traumatic bleeding?.
Binding affinity of different commercial FIX therapies to collagen IV Oct 1, 2023 - Sep 30, 2024
Haemophilia B is a blood clotting disorder caused by deficiency of blood coagulation Factor IX (FIX), resulting in bruising and bleeding. Haemophilia B affects 1:30,000 males in the UK and is treated by infusion of FIX concentrate to sustain normal f...
Read More about Binding affinity of different commercial FIX therapies to collagen IV.
Sustainable Production of Bitumen Substitute from Waste Tyres Nov 1, 2023 - Apr 30, 2024
This proposal aims to evaluate the feasibility, performance, and environmental benefits of using bitumen produced from waste tyre in road construction. The trial aims to determine the suitability of this alternative material as a sustainable option f...
Read More about Sustainable Production of Bitumen Substitute from Waste Tyres.